An activist investor urged Kohl’s to consider a sale; Alibaba is reorganizing its e-commerce teams

im 424454?width=700&height=466

Cryptocurrencies including Shiba Inu moved sharply lower over the weekend.

Photo: Jakub Porzycki/Zuma Press

Stock futures are mixed as investors consider a small study suggesting that the Omicron variant may cause milder disease. Here’s what we’re watching in Monday’s trading:

  • Cryptocurrencies are stabilizing after a weekend rout dragged bitcoin prices down by more than 20%. Other widely traded cryptocurrencies including Solana, Dogecoin and Shiba Inu coin at one point lost more than one-fifth of their value. Bitcoin on Monday traded at around $48,600, over 9% down on its level at 5 p.m. ET Friday, but up from Saturday’s low of $42,000.
  • Crypto stocks were showing strains. Bitcoin wallet provider Coinbase shed 4.6% premarket, and bitcoin miner Marathon Digital dropped 8%.
  • CF Acquisition shares soared 20% ahead of the bell. The blank-check company sponsored by financial-services firm Cantor Fitzgerald last week agreed to combine with video platform Rumble.
  • Kohl’s shares added 3.5% premarket. An activist investor is urging the department-store chain to consider a sale of the company or a separation of its e-commerce business.
  • Adicet Bio shares rocketed 41% higher. The biotech said it had received positive data from a phase 1 trial of a potential treatment for Non-Hodgkin’s lymphoma.
  • U.S.-traded shares of Alibaba gained 1.3%. The Chinese tech giant said it would reorganize its e-commerce teams and appointed a new chief financial officer, as it faces increasing competition in China, slowing growth and a plummeting stock price.
  • Crude prices were gaining, and producers’ stocks were along for the ride. Occidental Petroleum gained 2.5% and ConocoPhillips added 1.1%.
  • Coupa Software ,   GitLab and  HealthEquity  will deliver quarterly updates after the close.
Chart of the Day
  • Focusing on environmental, social and governance criteria has helped Nasdaq draw new listings of $191 billion so far this year, compared with $109 billion at NYSE.

Write to James Willhite at

Resume Subscription

We are delighted that you’d like to resume your subscription.

You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.

Please click confirm to resume now.